| pubmed-article:8452112 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8452112 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:8452112 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:8452112 | lifeskim:mentions | umls-concept:C1514695 | lld:lifeskim |
| pubmed-article:8452112 | lifeskim:mentions | umls-concept:C0684224 | lld:lifeskim |
| pubmed-article:8452112 | lifeskim:mentions | umls-concept:C1517927 | lld:lifeskim |
| pubmed-article:8452112 | lifeskim:mentions | umls-concept:C0015661 | lld:lifeskim |
| pubmed-article:8452112 | lifeskim:mentions | umls-concept:C0206034 | lld:lifeskim |
| pubmed-article:8452112 | lifeskim:mentions | umls-concept:C0205088 | lld:lifeskim |
| pubmed-article:8452112 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:8452112 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:8452112 | pubmed:dateCreated | 1993-4-14 | lld:pubmed |
| pubmed-article:8452112 | pubmed:abstractText | Between June 1977 and April 1983 the Radiation Therapy Oncology Group (RTOG) sponsored a Phase III randomized trial investigating the use of fast neutron radiotherapy for patients with locally advanced (Stages C and D1) adenocarcinoma of the prostate gland. Patients were randomized to receive either conventional photon radiation or fast neutron radiation used in a mixed-beam (neutron/photon) treatment schedule. A total of 91 analyzable patients were entered into the study, and the two patient groups were balanced with respect to the major prognostic variables. Actuarial curves are presented for local/regional control and "overall" survival. Ten-year results for clinically assessed local control are 70% for the mixed-beam group versus 58% for the photon group (p = 0.03) and for survival are 46% for the mixed-beam group versus 29% for the photon group (p = 0.04). This study suggests that a regional method of treatment can influence both local tumor control and survival in patients with locally advanced adenocarcinoma of the prostate gland. | lld:pubmed |
| pubmed-article:8452112 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8452112 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8452112 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8452112 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8452112 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8452112 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8452112 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8452112 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:8452112 | pubmed:issn | 0277-3732 | lld:pubmed |
| pubmed-article:8452112 | pubmed:author | pubmed-author:HendricksonF... | lld:pubmed |
| pubmed-article:8452112 | pubmed:author | pubmed-author:GriffinT WTW | lld:pubmed |
| pubmed-article:8452112 | pubmed:author | pubmed-author:LaramoreG EGE | lld:pubmed |
| pubmed-article:8452112 | pubmed:author | pubmed-author:DavisL WLW | lld:pubmed |
| pubmed-article:8452112 | pubmed:author | pubmed-author:KrallJ MJM | lld:pubmed |
| pubmed-article:8452112 | pubmed:author | pubmed-author:MaorM HMH | lld:pubmed |
| pubmed-article:8452112 | pubmed:author | pubmed-author:MartzK LKL | lld:pubmed |
| pubmed-article:8452112 | pubmed:author | pubmed-author:ThomasF JFJ | lld:pubmed |
| pubmed-article:8452112 | pubmed:author | pubmed-author:RussellK JKJ | lld:pubmed |
| pubmed-article:8452112 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8452112 | pubmed:volume | 16 | lld:pubmed |
| pubmed-article:8452112 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8452112 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8452112 | pubmed:pagination | 164-7 | lld:pubmed |
| pubmed-article:8452112 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:8452112 | pubmed:meshHeading | pubmed-meshheading:8452112-... | lld:pubmed |
| pubmed-article:8452112 | pubmed:meshHeading | pubmed-meshheading:8452112-... | lld:pubmed |
| pubmed-article:8452112 | pubmed:meshHeading | pubmed-meshheading:8452112-... | lld:pubmed |
| pubmed-article:8452112 | pubmed:meshHeading | pubmed-meshheading:8452112-... | lld:pubmed |
| pubmed-article:8452112 | pubmed:meshHeading | pubmed-meshheading:8452112-... | lld:pubmed |
| pubmed-article:8452112 | pubmed:meshHeading | pubmed-meshheading:8452112-... | lld:pubmed |
| pubmed-article:8452112 | pubmed:meshHeading | pubmed-meshheading:8452112-... | lld:pubmed |
| pubmed-article:8452112 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8452112 | pubmed:articleTitle | Fast neutron radiotherapy for locally advanced prostate cancer. Final report of Radiation Therapy Oncology Group randomized clinical trial. | lld:pubmed |
| pubmed-article:8452112 | pubmed:affiliation | Department of Radiation Oncology, University of Washington Medical Center, Seattle 98195. | lld:pubmed |
| pubmed-article:8452112 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8452112 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8452112 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:8452112 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8452112 | lld:pubmed |
